Wikidata

(Q74358564)

English

Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer

scientific article published on 01 March 1998

In more languages

Statements

title
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9516378
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516378%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 November 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q74358564&oldid=1754014176"